Correlation of the plasma level of insulin-like growth factor-1 with the number of aberrant crypt foci in male individuals

Molecular Medicine Reports

Volumn 2, Issue 3, 2009, Pages 339-343

  Takahashi, Hirokazu ^a   Takayama, Tetsuji ^b   Hosono, Kunihiro ^a   Yoneda, Kyoko ^a   Endo, Hiroki ^a   Nozaki, Yuichi ^a   Fujita, Koji ^a   Yoneda, Masato ^a   Inamori, Masahiko ^a   Abe, Yasunobu ^a   Kobayashi, Noritoshi ^a   Kirikoshi, Hiroyuki ^a   Kubota, Kensuke ^a   Saito, Satoru ^a   Nakagama, Hitoshi ^c   Nakajima, Atsushi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Aberrant crypt foci; Colorectal carcinogenesis; Insulin like growth factor 1

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; SOMATOMEDIN C;

ABERRANT CRYPT FOCI; ADULT; AGE; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CANCER GROWTH; CANCER RISK; COLON; COLON CARCINOGENESIS; COLONOSCOPY; COLORECTAL CANCER; DIABETES MELLITUS; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRECANCER; PROTEIN BLOOD LEVEL; RECTUM;

EID: 69249114256     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000105     Document Type: Article

References (33)

1. Anderson WF, Umar A and Brawley OW: Colorectal carcinoma in black and white race. Cancer Metastasis Rev 22: 67-82, 2003. (Pubitemid 36363515)
2. Rougier P and Mitry E: Epidemiology, treatment and chemoprevention in colorectal cancer. Ann Oncol 14: 3-5, 2003. (Pubitemid 36874131)
3. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH and Paul O: Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet i: 307-309, 1985. (Pubitemid 15157126)
4. Bird RP: Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37: 147-151, 1987.
5. Pretlow TP, O'Riordan MA, Somich GA, Amini SB and Pretlow TG: Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 13: 1509-1512, 1992.
6. Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, Kato J, Kogawa K, Miyake H and Niitsu Y: Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 339: 1277-1284, 1998. (Pubitemid 28496193)
7. Elwing JE, Gao F, Davidson NO and Early DS: Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women. Am J Gastroenterol 101: 1866-1871, 2006.
8. Watkins L, Lewis L and Levine A: Characterization of the synergistic effect of insulin and transferring and the regulation of their receptors on a human colon carcinoma cell line. Int J Cancer 45: 372-375, 1990. (Pubitemid 20061396)
9. Giovannucci E: Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131: S3109-S3120, 2001.
10. Guo YS, Narayan S, Yallampalli C and Singh P: Characterization of insulin-like growth factor 1 receptors in human colon cancer. Gastroenterology 102: 1101-1108, 1992.
11. MacDonald RS, Thornton WH and Bean TL: Insulin and IGF-1 receptors in a human intestinal adenocarcinoma cell line (Caco-2) regulation of Nat glucose transport across the brush border. J Recept Res 13: 1093-1113, 1993. (Pubitemid 23204738)
12. Jørgensen JO, Vahl N, Hansen TB, Skjaerbaek C, Fisker S, Orskov H, Hagen C and Christiansen JS: Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared with healthy subjects. Clin Endocrinol 48: 479-486, 1998. (Pubitemid 28258821)
13. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosén T, Lindstedt G, Lundberg PA and Bengtsson BA: Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol 41: 351-357, 1994. (Pubitemid 24278330)
14. Yamamoto H, Sohmiya M, Oka N and Kato Y: Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levels in normal adults. Acta Endocrinol 124: 497-500, 1991.
15. Roncucci L, Stamp D, Medline A, Cullen JB and Bruce WR: Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 22: 287-294, 1991.
16. Roncucci L, Medline A and Bruce WR: Classification of aberrant crypt foci and microadenomas in human colon. Cancer Epidemiol Biomarkers Prev 1: 57-60, 1991.
17. Pretlow TP, Barrow BJ, Ashton WS, O'Riordan MA, Pretlow TG, Jurcisek JA and Stellato TA: Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 51: 1564-1567, 1991.
18. Pretlow TP, O'Riordan MA, Pretlow TG and Stellato TA: Aberrant crypts in human colonic mucosa: putative preneoplastic lesions. J Cell Biochem 16 (Suppl): 55-62, 1992.
19. Schiel R, Beltschikow W, Steiner T and Stein G: Diabetes, insulin, and risk of cancer. Methods Find Exp Clin Pharmacol 28: 169-175, 2006.
20. Pollak M: Insulin-like growth factor physiology and cancer risk. Eur J Cancer 36: 1224-1228, 2000. (Pubitemid 30407009)
21. Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87: 159-170, 1996.
22. Aparicio T, Kotelevets L, Tsocas A, Laigneau JP, Sobhani I, Chastre E and Lehy T: Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/+) mice. Gut 54: 1136-1145, 2005.
23. De Fronzo RA: Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88: 787-835, 2004.
24. Koenuma M, Yamori T and Tsuruo T: Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res 80: 51-58, 1989. (Pubitemid 20027198)
25. Wu X, Fan Z, Masui H, Rosen N and Mendelsohn J: Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J Clin Invest 95: 1897-1905, 1995.
26. Tran TT, Medline A and Bruce WR: Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 5: 1013-1015, 1996. (Pubitemid 26415875)
27. Corpet DE, Jacquinet C, Peiffer G, et al: Insulin injections promote the growth of aberrant crypt foci in the colon of rats. Nutr Cancer 27: 316-320, 1997. (Pubitemid 27161531)
28. Limburg PJ, Vierkant RA, Fredericksen ZS, Leibson CL, Rizza RA, Gupta AK, Ahlquist DA, Melton LJ III, Sellers TA and Cerhan JR: Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol 101: 1872-1879, 2006.
29. Stumvoll M, Goldstein BJ and van Haeften TW: Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365: 1333-1346, 2005. (Pubitemid 40501297)
30. Pfeifle B, Hamann H, Fussganger R and Ditschuneit H: Insulin as a growth regulator of arterial smooth muscle cells: effect of insulin of I.G.F.I. Diabetes Metab 13: 326-330, 1987. (Pubitemid 17105093)
31. Jones J and Clemmons D: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34, 1995.
32. Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM and Clemmons DR: Hormonal and nutritional regulation of IGF-1 and its binding proteins. Horm Res 42: 145-151, 1994. (Pubitemid 24336142)
33. Smith WJ, Underwood LE and Clemmons DR: Effects of caloric or protein restriction on insulin-like growth factor-1 (IGF-1) and IGF binding proteins in children and adults. J Clin Endocrinol Metab 80: 443-449, 1995.